{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/menopause/","result":{"data":{"firstChapter":{"id":"0359e5fa-1342-5767-a4da-2f8b5cd2b6db","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field e11811df-2c27-42d3-bdce-1d21cb03c01c --><h1>Menopause: Summary</h1><!-- end field e11811df-2c27-42d3-bdce-1d21cb03c01c -->","htmlStringContent":"<!-- begin item 06e39ad8-84aa-41aa-b2e1-a09786e49739 --><!-- begin field ca12b1bc-1e39-4140-b1e4-a695d43c8320 --><ul><li>Menopause is when menstruation stops permanently due to the loss of ovarian follicular activity. It occurs with the final menstrual period and is usually diagnosed clinically after 12 months of amenorrhoea.<ul><li>In the UK, the mean age of natural menopause is 51 years.</li></ul></li><li>Perimenopause is the period before the menopause characterized by irregular cycles of ovulation and menstruation and ends 12 months after the last menstrual period.</li><li>Postmenopause is the time after a woman has not had a menstrual period for 12 consecutive months.</li><li>Early menopause is the cessation of ovarian function between 40 and 45 years, in the absence of other causes of secondary amenorrhoea.</li><li>Premature ovarian insufficiency (POI) is a clinical syndrome defined as the transient or permanent loss of ovarian function before the age of 40 years.</li><li>A diagnosis of perimenopause or menopause should be suspected if there:<ul><li>Is a change to the menstrual pattern.</li><li>Are symptoms including hot flushes/night sweats (vasomotor symptoms), mood disorders, urogenital symptoms, altered sexual function, sleep disturbance, and fatigue.</li></ul></li><li>Serum follicle-stimulating hormone (FSH) should not be used to diagnose perimenopause or menopause in otherwise healthy women (who are not using hormonal contraception) aged over 45 years, with typical symptoms.<ul><li>Measurement of serum FSH may be considered in women aged over 45 years with atypical symptoms; aged between 40–45 years with symptoms; and younger than 40 years with suspected POI.</li></ul></li><li>Assessment of a woman with suspected menopause should include:<ul><li>Asking about symptoms and impact on quality of life, lifestyle, contraception, smear status, family history, previous treatment(s) and wishes, current medication, and co-morbid conditions.</li></ul></li><li>Management of women with menopause should include advice on:<ul><li>Sources of information and support.</li><li>Lifestyle measures for symptom relief, such as exercise, weight loss, adequate sleep, and stress reduction.</li><li>Screening, bone health, and contraception.</li></ul></li><li>Management of women requesting hormone replacement therapy (HRT) should include:<ul><li>Enabling an informed choice of preparation, based on age, symptoms, and co-morbidities, including discussion of risks, benefits, adverse effects, and contraindications.</li><li>Prescribing the lowest dose for the shortest possible duration.</li><li>Offering an oestrogen plus progestogen preparation for women with a uterus, or oestrogen-only preparation for women without a uterus.</li><li>Offering low-dose vaginal oestrogen first-line for urogenital symptoms.</li><li>Arranging regular review to assess the efficacy and tolerability of treatment(s), adjusting the dose or preparation if needed, and advice on stopping HRT.</li></ul></li><li>Management of women where HRT is not tolerated or contraindicated should include:<ul><li>Offering antidepressants, clonidine, gabapentin, and/or cognitive behavioural therapy (CBT) for vasomotor symptoms, depending on her wishes and local service provision.</li><li>Offering self-help resources and CBT for mood disorders.</li><li>Vaginal moisturizers and/or lubricants for urogenital symptoms.</li><li>Arranging regular review to assess the efficacy and tolerability of treatment(s).</li></ul></li><li>Referral to a specialist should be offered if there:<ul><li>Are ongoing symptoms despite treatment.</li><li>Are persistent, troublesome adverse effects.</li><li>Is uncertainty about the most suitable treatment option.</li><li>Is uncertainty about the diagnosis or management of POI.</li></ul></li></ul><!-- end field ca12b1bc-1e39-4140-b1e4-a695d43c8320 --><!-- end item 06e39ad8-84aa-41aa-b2e1-a09786e49739 -->","topic":{"id":"69003588-b736-585d-8a5d-7ca0e916caa5","topicId":"f75fa6a7-10c6-4887-9cf1-3ea14d7f353c","topicName":"Menopause","slug":"menopause","aliases":[],"chapters":[{"id":"0359e5fa-1342-5767-a4da-2f8b5cd2b6db","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"c978ff88-dda8-5879-a0ac-9b09182d81d1","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"d381eed9-6611-5263-a3be-b46ec9f02058","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"ddcba55c-566e-5433-8dce-2e5f5cee0ba4","slug":"changes","fullItemName":"Changes"},{"id":"e521b2f5-34d4-580f-b63d-a1ec2d0c13a3","slug":"update","fullItemName":"Update"}]},{"id":"ab5690cf-81b4-5fa9-b69f-27abc2e034a3","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"c0f45ff8-442c-5027-922e-12d108200960","slug":"goals","fullItemName":"Goals"},{"id":"8459ae09-bdf2-5d0d-9728-538e93d05a8f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"43027e52-84ef-53fa-88c5-a84289154e48","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4620ee3c-97ae-5f9f-8bac-fc8497801cdb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b26fb3cf-562a-595a-8f9e-92fd752d2e6b","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"10c1cb80-22cc-5889-8e30-35cf1a9843bf","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"18c173af-ec8a-571c-be49-d894f0bec50b","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"8e86f5f5-2343-5ea3-8d0d-7dda791a066e","slug":"definition","fullItemName":"Definition"},{"id":"17295b39-3f33-5e75-8d8a-1fc32c2efb70","slug":"causes","fullItemName":"Causes"},{"id":"5b768dab-f7db-50c3-8686-0d363f36e74d","slug":"prevalence","fullItemName":"Prevalence"},{"id":"698848d3-f122-5e5a-acc8-98518854f51b","slug":"complications","fullItemName":"Complications"},{"id":"647a928d-775d-5b0b-b577-b695140b26a3","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"00aeafb7-f9e4-5fd2-8fd2-57bd7fd333d8","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"d68ce2dd-2971-5c66-b22c-df0db848cf06","slug":"diagnosis-of-menopause-perimenopause","fullItemName":"Diagnosis of menopause and perimenopause"},{"id":"8b9c8208-91c2-5751-8a76-dc9461736050","slug":"diagnosis-of-premature-ovarian-insufficiency","fullItemName":"Diagnosis of premature ovarian insufficiency"},{"id":"a84016e1-b7af-55f9-b1f8-c85ff76cfc93","slug":"assessment","fullItemName":"Assessment"},{"id":"6c51a87c-f89c-5e58-b495-39506bc70e62","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"649507f8-7b95-5740-9833-fee7c5bff092","slug":"management","fullItemName":"Management","subChapters":[{"id":"9c13d541-f2ee-5d0a-a174-cd7c7b4aa392","slug":"management-of-menopause-perimenopause-or-premature-ovarian-insufficiency","fullItemName":"Scenario: Management of menopause, perimenopause, or premature ovarian insufficiency"}]},{"id":"7d937659-3134-52f9-8742-b90a6ffb1f1f","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"19b6008a-dd02-5fdb-b146-5cb427bb1f29","slug":"hormone-replacement-therapy-hrt","fullItemName":"Hormone replacement therapy (HRT)"}]},{"id":"ff6b5c36-2033-50a7-9c74-c9e46f1c8242","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"c9280136-8c1b-5890-96e2-c8f14078bb5f","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"4f9c2c0d-8ea0-5048-8ae4-0b2517bed5ca","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4b187b70-dcd7-5e05-ac85-fd75204e2515","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b3e44a7a-44e1-5dec-bd9e-67a0cad5baca","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6e1b4175-c43f-53ce-8884-b9f1b5b39f58","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6e0d3a8f-c4c1-533c-b265-34d08681175b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e6340cdd-13d8-5fde-912f-a3d2c50f305f","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"69003588-b736-585d-8a5d-7ca0e916caa5","topicId":"f75fa6a7-10c6-4887-9cf1-3ea14d7f353c","topicName":"Menopause","slug":"menopause","aliases":[],"topicSummary":"Menopause is a biological stage in a woman's life when menstruation ceases permanently due to the loss of ovarian follicular activity.","lastRevised":"Last revised in November 2020","nextPlannedReviewBy":"2025-11-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2025-11","nextPlannedReviewByDisplay":"November 2025","specialities":[{"id":"0c813417-9691-5826-9371-c4bec6c53f06","name":"Women's health","slug":"womens-health"}],"chapters":[{"id":"0359e5fa-1342-5767-a4da-2f8b5cd2b6db","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"c978ff88-dda8-5879-a0ac-9b09182d81d1","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"d381eed9-6611-5263-a3be-b46ec9f02058","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"ddcba55c-566e-5433-8dce-2e5f5cee0ba4","slug":"changes","fullItemName":"Changes"},{"id":"e521b2f5-34d4-580f-b63d-a1ec2d0c13a3","slug":"update","fullItemName":"Update"}]},{"id":"ab5690cf-81b4-5fa9-b69f-27abc2e034a3","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"c0f45ff8-442c-5027-922e-12d108200960","slug":"goals","fullItemName":"Goals"},{"id":"8459ae09-bdf2-5d0d-9728-538e93d05a8f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"43027e52-84ef-53fa-88c5-a84289154e48","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4620ee3c-97ae-5f9f-8bac-fc8497801cdb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b26fb3cf-562a-595a-8f9e-92fd752d2e6b","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"10c1cb80-22cc-5889-8e30-35cf1a9843bf","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"18c173af-ec8a-571c-be49-d894f0bec50b","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"8e86f5f5-2343-5ea3-8d0d-7dda791a066e","slug":"definition","fullItemName":"Definition"},{"id":"17295b39-3f33-5e75-8d8a-1fc32c2efb70","slug":"causes","fullItemName":"Causes"},{"id":"5b768dab-f7db-50c3-8686-0d363f36e74d","slug":"prevalence","fullItemName":"Prevalence"},{"id":"698848d3-f122-5e5a-acc8-98518854f51b","slug":"complications","fullItemName":"Complications"},{"id":"647a928d-775d-5b0b-b577-b695140b26a3","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"00aeafb7-f9e4-5fd2-8fd2-57bd7fd333d8","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"d68ce2dd-2971-5c66-b22c-df0db848cf06","slug":"diagnosis-of-menopause-perimenopause","fullItemName":"Diagnosis of menopause and perimenopause"},{"id":"8b9c8208-91c2-5751-8a76-dc9461736050","slug":"diagnosis-of-premature-ovarian-insufficiency","fullItemName":"Diagnosis of premature ovarian insufficiency"},{"id":"a84016e1-b7af-55f9-b1f8-c85ff76cfc93","slug":"assessment","fullItemName":"Assessment"},{"id":"6c51a87c-f89c-5e58-b495-39506bc70e62","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"649507f8-7b95-5740-9833-fee7c5bff092","slug":"management","fullItemName":"Management","subChapters":[{"id":"9c13d541-f2ee-5d0a-a174-cd7c7b4aa392","slug":"management-of-menopause-perimenopause-or-premature-ovarian-insufficiency","fullItemName":"Scenario: Management of menopause, perimenopause, or premature ovarian insufficiency"}]},{"id":"7d937659-3134-52f9-8742-b90a6ffb1f1f","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"19b6008a-dd02-5fdb-b146-5cb427bb1f29","slug":"hormone-replacement-therapy-hrt","fullItemName":"Hormone replacement therapy (HRT)"}]},{"id":"ff6b5c36-2033-50a7-9c74-c9e46f1c8242","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"c9280136-8c1b-5890-96e2-c8f14078bb5f","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"4f9c2c0d-8ea0-5048-8ae4-0b2517bed5ca","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4b187b70-dcd7-5e05-ac85-fd75204e2515","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b3e44a7a-44e1-5dec-bd9e-67a0cad5baca","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6e1b4175-c43f-53ce-8884-b9f1b5b39f58","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6e0d3a8f-c4c1-533c-b265-34d08681175b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e6340cdd-13d8-5fde-912f-a3d2c50f305f","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"69003588-b736-585d-8a5d-7ca0e916caa5"}},"staticQueryHashes":["3666801979"]}